1. United States Stocks

  2. •

    Health technology

  3. •

    Biotechnology
First Tracks Biotherapeutics, Inc.

First Tracks Biotherapeutics, Inc.

30.30
EUR
- -
- -
-0.83EPS
Dec 02Next Earn

Important Dates

First Tracks Biotherapeutics Inc's next confirmed earnings release is scheduled for December 2, 2026.

Earnings Date12/2/2026

Share Statistics

As of June 30, 2026, First Tracks Biotherapeutics Inc has 35.39M shares outstanding.

Shares Outstanding35.39M

Financial Position

As of June 30, 2026, First Tracks Biotherapeutics Inc maintains a current ratio of 14.28, meaning it holds 14.3x the short-term assets needed to cover near-term liabilities.

Current Ratio14.28
Quick Ratio13.91
Debt / Equity2.57

Income Statement

EUR

These figures cover the twelve months ended June 30, 2026.

Pretax Income-29.21M

Balance Sheet

EUR

As of June 30, 2026, First Tracks Biotherapeutics Inc holds 147.07M in cash and equivalents against 3.79M in total debt, resulting in a net debt position of -147.07M. Total book value stands at 147.75M, with working capital of 144.69M providing operational flexibility.

Cash & Cash Equivalents147.07M
Total Debt3.79M
Net Debt-147.07M
Equity (Book Value)147.75M
Book Value Per Share4.17
Working Capital144.69M

Cash Flow

EUR

These figures cover the twelve months ended June 30, 2026. After subtracting -21,882.50 in capital expenditures, free cash flow totaled -27.96M - equivalent to -0.80 per share.

Capital Expenditures-21,882.50
Free Cash Flow-27.96M
FCF Per Share-0.80